Combination therapy with misonidazole and mitomycin C: Lack of chemosensitization of EMT6 tumor cells in vivo or in vitro
β Scribed by Sara Rockwell
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 463 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Interleukin -I I (rhlL-I I) is a cytokine that has been shown to enhance the recovery of bone marrow and intestinal crypt cells after cytotoxic insult with radiation or anticancer drugs. The current study examined the effects of rhlL-I I on the response of CEM human lymphoblastic leukemia cells
## Abstract The purpose of this study was to determine the differential effects of therapeutic Xβradiation on constituent bone cells relative to the pediatric tumor cells: Ewing's sarcoma of bone and rhabdomyosarcoma. In addition, the radioprotectant drugs amifostine and sodium selenite were admini